Cargando…

Effects of the CB1 Receptor Antagonists AM6545 and AM4113 on Insulin Resistance in a High-Fructose High-Salt Rat Model of Metabolic Syndrome

Background and Objectives: Insulin resistance (IR) is a serious condition leading to development of diabetes and cardiovascular complications. Hyper-activation of cannabinoid receptors-1 (CB1) has been linked to the development of metabolic disorders such as IR. Therefore, the effect of blocking CB1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eid, Basma G., Neamatallah, Thikryat, Hanafy, Abeer, El-Bassossy, Hany M., Aldawsari, Hibah M., Vemuri, Kiran, Makriyannis, Alexandros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692885/ https://www.ncbi.nlm.nih.gov/pubmed/33138155 http://dx.doi.org/10.3390/medicina56110573

Ejemplares similares

Effects of the CB1 receptor antagonists AM6545 and AM4113 on metabolic syndrome-induced prostatic hyperplasia in rats
por: Eid, Basma G, et al.
Publicado: (2023)

Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome
por: Eid, Basma G., et al.
Publicado: (2021)

The CB(1) Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability
por: Gueye, Aliou B., et al.
Publicado: (2016)

Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice
por: Ma, Haiming, et al.
Publicado: (2018)

Anticonvulsant and Neuroprotective Activities of Phragmanthera austroarabica Extract in Pentylenetetrazole-Kindled Mice
por: Aldawsari, Hibah M., et al.
Publicado: (2017)

Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite
por: Honrao, Chandrashekhar, et al.
Publicado: (2020)

Corrigendum: Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite
por: Honrao, Chandrashekhar, et al.
Publicado: (2021)

Treatment of Diet-Induced Obese Rats with CB(2) Agonist AM1241 or CB(2) Antagonist AM630 Reduces Leptin and Alters Thermogenic mRNA in Adipose Tissue
por: O’Keefe, Lannie, et al.
Publicado: (2023)

Abuse Potential of Synthetic Cannabinoids: AM-1248, CB-13, and PB-22
por: Hur, Kwang-Hyun, et al.
Publicado: (2021)

Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic Rats
por: Spyridakos, Dimitris, et al.
Publicado: (2022)

AMS
por: Marcastel, Fabienne CERN Graphic Design service
Publicado: (2013)

CB2 Agonist (AM1241) Improving Effect on Ovalbumin-Induced Asthma in Rats
por: Parlar, Ali, et al.
Publicado: (2020)

Lipidic Nano-Sized Emulsomes Potentiates the Cytotoxic and Apoptotic Effects of Raloxifene Hydrochloride in MCF-7 Human Breast Cancer Cells: Factorial Analysis and In Vitro Anti-Tumor Activity Assessment
por: Aldawsari, Hibah M., et al.
Publicado: (2021)

The flight of AMS = Il volo di AMS
por: Famiglietti, Michele, et al.
Publicado: (2012)

I Am, I Am, I Am: Seventeen Brushes With Death, by Maggie O’Farrell
por: Moullaali, Tom J, et al.
Publicado: (2020)

Icariin enhances AMP-activated protein kinase and prevents high fructose and high salt-induced metabolic syndrome in rats
por: Aljehani, Abeer A., et al.
Publicado: (2020)

AMS WITH ASTRONAUTS
por: Vanden Broeck, Renilde
Publicado: (2019)

AMS - DETECTOR
por: Vanden Broeck, Renilde
Publicado: (2019)

AMS - ISS
por: Vanden Broeck, Renilde
Publicado: (2019)

AMS - LAUNCH
por: Vanden Broeck, Renilde
Publicado: (2019)

AMS - LIFETIME
por: Vanden Broeck, Renilde
Publicado: (2019)

AMS - ON THE STATION
por: Vanden Broeck, Renilde
Publicado: (2019)

OpenAM
por: Thangasamy, Indira
Publicado: (2011)

The AMS Experiment
por: AMS Collaboration
Publicado: (2007)

AMS Highlights
por: Berdugo Pérez, Javier
Publicado: (2022)

I Am Not a Scientist, I Am a Number
por: Bourne, Philip E., et al.
Publicado: (2008)

AMS-high energy gamma-ray physics potential
por: Lamanna, G
Publicado: (2003)

Erstes LHC-Experiment am 10.September am Kernforschungszentrum CERN
Publicado: (2008)

Inside the bulk of magnetic nanocomposites: I am not what I am
por: Stuhrmann, Heinrich B.
Publicado: (2015)

Mitogen-Activated Protein Kinase Pathway: A Critical Regulator in Tumor-associated Macrophage Polarization
por: Neamatallah, Thikryat
Publicado: (2019)

Delayed inflammatory reaction to hyaluronic acid lip filler after the Pfizer-BioNTech COVID-19 vaccine: A case report
por: Neamatallah, Thikryat
Publicado: (2023)

Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism
por: Neamatallah, Thikryat, et al.
Publicado: (2020)

Correction: Neamatallah et al. Nano Ellagic Acid Counteracts Cisplatin-Induced Upregulation in OAT1 and OAT3: A Possible Nephroprotection Mechanism. Molecules 2020, 25, 3031
por: Neamatallah, Thikryat, et al.
Publicado: (2023)

AMD AM29116
Publicado: (1982)

AMS - DARK MATTER
por: Vanden Broeck, Renilde
Publicado: (2019)

AMS - ROLL-OUT
por: Vanden Broeck, Renilde
Publicado: (2019)

Introduction to the AMS Experiment
por: Prof. TING, Samuel
Publicado: (2015)

Aufbegehren am CERN
Publicado: (2000)

AMS ready for launch
por: Katarina Anthony
Publicado: (2011)

Results of the AMS experiment
por: Ting, Samuel C C
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_5b1klu8a8hcom9kb2cs7vbt3us